NZ206063A - Pyrido(2,3-d)pyrimidin-5-one derivatives and pharmaceutical compositions - Google Patents
Pyrido(2,3-d)pyrimidin-5-one derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ206063A NZ206063A NZ206063A NZ20606383A NZ206063A NZ 206063 A NZ206063 A NZ 206063A NZ 206063 A NZ206063 A NZ 206063A NZ 20606383 A NZ20606383 A NZ 20606383A NZ 206063 A NZ206063 A NZ 206063A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pyridinyl
- pyrido
- pyrimidin
- carbon atoms
- alkyl
- Prior art date
Links
- QAVNHOYEYANRDW-UHFFFAOYSA-N 6h-pyrido[2,3-d]pyrimidin-5-one Chemical class C1=NC=C2C(=O)CC=NC2=N1 QAVNHOYEYANRDW-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- -1 alkaline earth metal salt Chemical class 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/439,361 US4432981A (en) | 1982-11-05 | 1982-11-05 | 2-(Pyridinyl or hydroxyphenyl)-8-substituted pyrido[2,3-d]pyrimidin-5(8H)-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ206063A true NZ206063A (en) | 1986-10-08 |
Family
ID=23744409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ206063A NZ206063A (en) | 1982-11-05 | 1983-10-26 | Pyrido(2,3-d)pyrimidin-5-one derivatives and pharmaceutical compositions |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4432981A (enExample) |
| EP (1) | EP0108380B1 (enExample) |
| JP (1) | JPS5995287A (enExample) |
| KR (1) | KR890001425B1 (enExample) |
| AT (1) | ATE40891T1 (enExample) |
| AU (1) | AU557800B2 (enExample) |
| CA (1) | CA1234111A (enExample) |
| DE (1) | DE3379223D1 (enExample) |
| DK (1) | DK503583A (enExample) |
| ES (1) | ES526992A0 (enExample) |
| FI (1) | FI76336C (enExample) |
| GR (1) | GR78750B (enExample) |
| IL (1) | IL70060A (enExample) |
| NO (1) | NO162558C (enExample) |
| NZ (1) | NZ206063A (enExample) |
| PH (1) | PH21605A (enExample) |
| PT (1) | PT77610B (enExample) |
| ZA (1) | ZA838178B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4560753A (en) * | 1982-11-05 | 1985-12-24 | Sterling Drug Inc. | 2-Substituted-pyrido[2,3-d]pyrimidin-5(8H)-ones |
| DE3438350A1 (de) * | 1984-10-19 | 1986-04-24 | Gödecke AG, 1000 Berlin | 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung |
| DE3438351A1 (de) * | 1984-10-19 | 1986-04-24 | Gödecke AG, 1000 Berlin | 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung |
| US5026851A (en) * | 1985-03-08 | 1991-06-25 | The Trustees Of Princeton University | Pyrido[2,3-]pyrimidine derivatives |
| ZA861235B (en) * | 1985-03-08 | 1986-10-29 | Univ Princeton | Pyrido(2,3-d)pyrimidine derivatives |
| US4684653A (en) * | 1985-03-08 | 1987-08-04 | The Trustees Of Princeton University | Pyrido(2,3-d)pyrimidine derivatives |
| US4927828A (en) * | 1985-03-08 | 1990-05-22 | The Trustees Of Princeton University | Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives |
| US4833145A (en) * | 1986-06-30 | 1989-05-23 | The Trustees Of Princeton University | 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives |
| US4902796A (en) * | 1986-10-20 | 1990-02-20 | The Trustees Of Princeton University | 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines |
| US4818819A (en) * | 1986-10-20 | 1989-04-04 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
| US5028608A (en) * | 1989-12-11 | 1991-07-02 | The Trustees Of Princeton University | N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3320257A (en) * | 1965-04-12 | 1967-05-16 | Sterling Drug Inc | Pyrido[2, 3-d]pyrimidines, pyrido[3, 2-d]pyrimidines, and intermediates and process therefor |
| US3642797A (en) * | 1968-06-10 | 1972-02-15 | Sterling Drug Inc | 4h-pyrido(1 2-a)pyrimidin-4-ones |
| JPS4837279B1 (enExample) * | 1970-08-29 | 1973-11-09 | ||
| US3673184A (en) * | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
| BE789496A (enExample) * | 1971-10-05 | 1973-03-29 | S M B Anciens Ets J Muelberger | |
| US3992380A (en) * | 1975-03-03 | 1976-11-16 | Sterling Drug Inc. | 5,8-Dihydro-5-oxo-2-(4-or 3-pyridinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acids and esters |
| US4018770A (en) * | 1975-03-03 | 1977-04-19 | Sterling Drug Inc. | N-(2-(pyridinyl)-4-pyrimidinyl)-aminomethylenemalonates and analogs |
-
1982
- 1982-11-05 US US06/439,361 patent/US4432981A/en not_active Expired - Fee Related
-
1983
- 1983-10-26 IL IL70060A patent/IL70060A/xx unknown
- 1983-10-26 NZ NZ206063A patent/NZ206063A/xx unknown
- 1983-10-31 FI FI833996A patent/FI76336C/fi not_active IP Right Cessation
- 1983-10-31 JP JP58204638A patent/JPS5995287A/ja active Pending
- 1983-10-31 AU AU20839/83A patent/AU557800B2/en not_active Ceased
- 1983-11-02 DE DE8383110912T patent/DE3379223D1/de not_active Expired
- 1983-11-02 EP EP83110912A patent/EP0108380B1/en not_active Expired
- 1983-11-02 AT AT83110912T patent/ATE40891T1/de not_active IP Right Cessation
- 1983-11-02 ZA ZA838178A patent/ZA838178B/xx unknown
- 1983-11-03 NO NO834010A patent/NO162558C/no unknown
- 1983-11-03 ES ES526992A patent/ES526992A0/es active Granted
- 1983-11-03 DK DK503583A patent/DK503583A/da not_active Application Discontinuation
- 1983-11-04 GR GR72880A patent/GR78750B/el unknown
- 1983-11-04 CA CA000440439A patent/CA1234111A/en not_active Expired
- 1983-11-04 KR KR1019830005242A patent/KR890001425B1/ko not_active Expired
- 1983-11-04 PT PT77610A patent/PT77610B/pt unknown
- 1983-11-04 PH PH29788A patent/PH21605A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE40891T1 (de) | 1989-03-15 |
| PH21605A (en) | 1987-12-11 |
| FI76336C (fi) | 1988-10-10 |
| AU557800B2 (en) | 1987-01-08 |
| PT77610A (en) | 1983-12-01 |
| CA1234111A (en) | 1988-03-15 |
| DE3379223D1 (de) | 1989-03-30 |
| NO162558B (no) | 1989-10-09 |
| IL70060A (en) | 1987-02-27 |
| ES8601986A1 (es) | 1985-11-16 |
| IL70060A0 (en) | 1984-01-31 |
| EP0108380A3 (en) | 1984-09-05 |
| ZA838178B (en) | 1984-06-27 |
| KR840006658A (ko) | 1984-12-01 |
| JPS5995287A (ja) | 1984-06-01 |
| NO834010L (no) | 1984-05-07 |
| US4432981A (en) | 1984-02-21 |
| FI833996A7 (fi) | 1984-05-06 |
| DK503583A (da) | 1984-05-06 |
| GR78750B (enExample) | 1984-10-02 |
| EP0108380B1 (en) | 1989-02-22 |
| FI833996A0 (fi) | 1983-10-31 |
| EP0108380A2 (en) | 1984-05-16 |
| ES526992A0 (es) | 1985-11-16 |
| PT77610B (pt) | 1986-03-19 |
| KR890001425B1 (ko) | 1989-05-03 |
| FI76336B (fi) | 1988-06-30 |
| AU2083983A (en) | 1984-05-10 |
| DK503583D0 (da) | 1983-11-03 |
| NO162558C (no) | 1990-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU557800B2 (en) | Pyrido(2,3-d) pyridimin-5-ones | |
| AU528275B2 (en) | Imidazole derivatives | |
| DE3169480D1 (en) | Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them | |
| ES476645A1 (es) | Procedimiento para la obtencion de derivados aminados de pi-razol (1,5-a)s troazina. | |
| ES553742A0 (es) | Un procedimiento para la preparacion de nuevos derivados de penem. | |
| GB1084150A (enExample) | ||
| ES8301239A1 (es) | Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas | |
| ES475596A1 (es) | Procedimiento para la preparacion de derivados de fenoxial- canolaminas | |
| ES8300776A1 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina | |
| GB2016002A (en) | Amino derivatives of pyrazolo[1,5-A]S.triazine | |
| ES8105319A1 (es) | Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas | |
| GB1218590A (en) | N-substituted piperidine spiro compounds | |
| JPS57102892A (en) | Thiopyranopyridobenzoxazol-7-one derivative | |
| JPS6425781A (en) | 7-deazapurine derivative and production thereof | |
| MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. |